Literature DB >> 27812842

Abrasive Endoprosthetic Wear Particles Inhibit IFN-γ Secretion in Human Monocytes Via Upregulating TNF-α-Induced miR-29b.

Yan-Min Bu1, De-Zhi Zheng1, Lei Wang1, Jun Liu2.   

Abstract

The adverse biological responses to prostheses wear particles commonly led to the failure of total hip arthroplasty. Among the released cytokines, interferon-γ (IFN-γ) has been found to be a critical functional factor during osteoclast differentiation. However, the molecular mechanism underlying the regulation of IFN-γ in wear particles-induced cells still needs to be determined. Four kinds of abrasive endoprosthetic wear particle were used to treat THP-1 cells, including polymethylmethacrylate (PMMA), zirconiumoxide (ZrO2), commercially pure titanium (cpTi), and titanium alloy (Ti-6Al-7Nb), with a concentration of 0.01, 0.05, 0.1, or 0.2 mg/ml for 48 h. The expression of IFN-γ and miR-29b was detected by real-time RT-PCR or ELISA. Luciferase reporter assay was performed to determine the regulation of miR-29b on IFN-γ. The effect of miR-29b inhibitor on the expression of wear particle-induced IFN-γ was detected. The expression of miR-29b was examined in THP-1 cells treated with tumor necrosis factor-alpha (TNF-α). The expression of IFN-γ was downregulated and the level of miR-29b was increased in THP-1 cells pretreated with wear particles. IFN-γ was a target of miR-29b. Wear particles inhibited the expression of IFN-γ through miR-29b. The expression of miR-29b was significantly reduced in THP-1 cells treated with TNF-α neutralizing antibody and particles comparing to that in the cells treated with particles alone. Wear particles inhibit the IFN-γ secretion in human monocytes, which was associated with the upregulating TNF-α-induced miR-29b.

Entities:  

Keywords:  IFN-γ; TNF-α; abrasive endoprosthetic wear particles; human monocytes; miR-29b

Mesh:

Substances:

Year:  2017        PMID: 27812842     DOI: 10.1007/s10753-016-0465-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

Review 1.  Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.

Authors:  Donald W Howie; Susan D Neale; David R Haynes; Oksana T Holubowycz; Margaret A McGee; Lucian B Solomon; Stuart A Callary; Gerald J Atkins; David M Findlay
Journal:  Inflammopharmacology       Date:  2013-10-15       Impact factor: 4.473

Review 2.  Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions.

Authors:  Shahryar Noordin; Bassam Masri
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

3.  miR-21 expression is related to particle-induced osteolysis pathogenesis.

Authors:  Yingchuan Zhou; Yi Liu; Li Cheng
Journal:  J Orthop Res       Date:  2012-04-16       Impact factor: 3.494

4.  Interferon-γ enhances the efficacy of autogenous bone grafts by inhibiting postoperative bone resorption in rat calvarial defects.

Authors:  Peiqi Li; Yoshitomo Honda; Yoshiyuki Arima; Kenichirou Yasui; Kaoru Inami; Aki Nishiura; Yoshiya Hashimoto; Naoyuki Matsumoto
Journal:  J Prosthodont Res       Date:  2016-02-09       Impact factor: 4.642

5.  Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts.

Authors:  Y Azuma; K Kaji; R Katogi; S Takeshita; A Kudo
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

6.  Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation.

Authors:  T Kagiya; S Nakamura
Journal:  J Periodontal Res       Date:  2012-10-18       Impact factor: 4.419

Review 7.  Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement.

Authors:  S B Goodman; E Gibon; J Pajarinen; T-H Lin; M Keeney; P-G Ren; C Nich; Z Yao; K Egashira; F Yang; Y T Konttinen
Journal:  J R Soc Interface       Date:  2014-01-29       Impact factor: 4.118

8.  Total hip arthroplasties: what are the reasons for revision?

Authors:  Slif D Ulrich; Thorsten M Seyler; Derek Bennett; Ronald E Delanois; Khaled J Saleh; Issada Thongtrangan; Michael Kuskowski; Edward Y Cheng; Peter F Sharkey; Javad Parvizi; James B Stiehl; Michael A Mont
Journal:  Int Orthop       Date:  2007-04-19       Impact factor: 3.075

Review 9.  Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.

Authors:  E M Schwarz; R J Looney; R J O'Keefe
Journal:  Arthritis Res       Date:  2000-03-27

Review 10.  Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.

Authors:  Hideki Kitaura; Keisuke Kimura; Masahiko Ishida; Haruka Kohara; Masako Yoshimatsu; Teruko Takano-Yamamoto
Journal:  Clin Dev Immunol       Date:  2013-05-23
View more
  3 in total

1.  miR-9-5p promotes wear-particle-induced osteoclastogenesis through activation of the SIRT1/NF-κB pathway.

Authors:  Liang Zhang; Weidong Zhao; Dongmei Bao; Kening Sun; Peng Li; Zhihui Gao; Zhidong Lu
Journal:  3 Biotech       Date:  2021-05-09       Impact factor: 2.893

2.  Wear particles enhance autophagy through up-regulation of CD147 to promote osteoclastogenesis.

Authors:  Baohua Su; Deng Li; Jie Xu; Yingbin Zhang; Zhiqing Cai; Max Daniel Kauther; Ruofan Ma
Journal:  Iran J Basic Med Sci       Date:  2018-08       Impact factor: 2.699

Review 3.  Exosome: Function and Application in Inflammatory Bone Diseases.

Authors:  Yingkun Hu; Yi Wang; Tianhong Chen; Zhuowen Hao; Lin Cai; Jingfeng Li
Journal:  Oxid Med Cell Longev       Date:  2021-08-31       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.